Live News EQUITY FLASH L impact Nov 05, 2026, 08:57 AM UTC Elicera Therapeutics Secures Chinese Patent Allowance for ELC-401 The patent allowance covers Elicera Therapeutics’ glioblastoma therapy ELC-401 in China. SquawkNews Desk